D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CY
2226
DELISTED
Cypress Semiconductor
CY
| $294K | ﹤0.01% |
+19,720
| New | +$294K |
|
|
MITT
2227
AG Mortgage Investment Trust
MITT
$245M
| $292K | ﹤0.01% |
5,776
-23,989
| -81% | -$1.21M |
|
|
TLGT
2228
DELISTED
Teligent, Inc
TLGT
| $291K | ﹤0.01% |
25,116
+4,743
| +23% | +$55K |
|
2229
Baker Hughes
BKR
$46.3B
| $290K | ﹤0.01% |
10,450
-6,635
| -39% | -$184K |
|
2230
Comstock Resources
CRK
$4.65B
| $289K | ﹤0.01% |
+41,771
| New | +$289K |
|
2231
Fox Factory Holding Corp
FOXF
$1.17B
| $289K | ﹤0.01% |
4,135
-12,103
| -75% | -$846K |
|
2232
FreightCar America
RAIL
$159M
| $289K | ﹤0.01% |
47,051
+15,738
| +50% | +$96.7K |
|
2233
NACCO Industries
NC
$293M
| $288K | ﹤0.01% |
7,531
+100
| +1% | +$3.82K |
|
2234
PDS Biotechnology
PDSB
$57.8M
| $288K | ﹤0.01% |
38,934
+1,746
| +5% | +$12.9K |
|
|
CTT
2235
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $286K | ﹤0.01% |
29,077
-143,434
| -83% | -$1.41M |
|
2236
Align Technology
ALGN
$9.64B
| $284K | ﹤0.01% |
1,000
-9,707
| -91% | -$2.76M |
|
2237
CONMED
CNMD
$1.63B
| $284K | ﹤0.01% |
3,412
-21,791
| -86% | -$1.81M |
|
2238
China Yuchai International
CYD
$1.39B
| $283K | ﹤0.01% |
17,848
-10,277
| -37% | -$163K |
|
2239
Lifecore Biomedical
LFCR
$262M
| $283K | ﹤0.01% |
23,068
+12,648
| +121% | +$155K |
|
|
EMKR
2240
DELISTED
Emcore Corp
EMKR
| $283K | ﹤0.01% |
+7,750
| New | +$283K |
|
2241
LoveSac
LOVE
$302M
| $282K | ﹤0.01% |
+10,136
| New | +$282K |
|
2242
Everspin Technologies
MRAM
$154M
| $282K | ﹤0.01% |
36,805
+22,470
| +157% | +$172K |
|
2243
NVE Corp
NVEC
$317M
| $282K | ﹤0.01% |
2,877
| – | – |
|
2244
NewtekOne
NEWT
$305M
| $281K | ﹤0.01% |
+14,326
| New | +$281K |
|
2245
Savara
SVRA
$662M
| $281K | ﹤0.01% |
38,075
+23,346
| +159% | +$172K |
|
|
ACRE
2246
Ares Commercial Real Estate
ACRE
$267M
| $279K | ﹤0.01% |
18,380
-126,553
| -87% | -$1.92M |
|
|
MRTX
2247
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $276K | ﹤0.01% |
3,763
-12,462
| -77% | -$914K |
|
2248
Coty
COTY
$3.51B
| $275K | ﹤0.01% |
+23,900
| New | +$275K |
|
2249
Cognex
CGNX
$7.45B
| $270K | ﹤0.01% |
+5,310
| New | +$270K |
|
|
AAT
2250
American Assets Trust
AAT
$1.25B
| $269K | ﹤0.01% |
5,875
-4,081
| -41% | -$187K |
|